Also called TCRBV21S3 Vβ21 is a subfamily of the T cell receptor. The Vβ21.3 is expressed by 2.2% to 3.6% of peripheral CD3+ cells in normal blood. This sequence is also referred to as TRBV11-2 (based on the IMGT gene nomenclature).

Specifications

Target Species Human
Specificity TCR Vβ21.3
Other Names TCR VBeta 21.3, TCRBV21S3
Fluorochrome FITC
Regulatory Status ASR
Size 1 mL
Format Liquid
Flow Product Line IOTest
Clone IG125
Isotype IgG2a Mouse
Clone Description The IG125 antibody recognizes the IGRb01 sequence identical to TCR BV21.3 sequence. Recognition of other sequences within this subfamily has not been found, but cannot be formally excluded.

Technical Documents

NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES
PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS

The listed regulatory status for products correspond to one of the below:
IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use."
ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagents. Analytical and performance characteristics are not established."
CE: Products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). (Note: Devices may be CE marked to other directives than (98/79/EC)
RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures."
LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only."
No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.